期刊文献+

浅谈处方集发展的历史、现状与构建原则 被引量:5

Simple Talk about the History,Current Situation and Constructing Principles of Formulary
下载PDF
导出
摘要 目的探讨在我国建立和推行处方集制度的问题。方法借鉴国外的相关政策和经验,就其医疗机构药品处方集系统的历史、现状、构建原则作简要介绍。结果面对不断增加的医疗费用,世界上许多国家的健康保险机构和卫生保健系统已经采取了一系列措施抑制药品费用,包括由消费者承担费用比例的增加和对开处方者采用限制性处方集。结论我国医院处方集的编制还处于探索阶段,希望国外的经验能对在我国推行处方集制度起到一定的积极作用。 Objective To explore the establishment and promotion of formulary in our country.Methods To introduce the history,current situation and constructing principles of formulary in hospital in order to use overseas policy and experience for reference.Results Faced with increasing costs,health insurers and health care systems have adopted a variety of strategies to contain drug expenditures including greater cost sharing by consumers and restricted formularies for prescribers.Conclusions At the present time, the formulary compile in our country is in exploration stage, hereby this paper absorb and draw lessons from overseas policy and experience, hope to help for carrying out formulary system in China.
机构地区 解放军第
出处 《中国药事》 CAS 2009年第10期1030-1032,共3页 Chinese Pharmaceutical Affairs
关键词 处方集 历史 现状 构建原则 借鉴 formulary history current situation constructing principle use for reference
  • 相关文献

参考文献18

  • 1Simon G E, Psaty B M, Hrachoves J B, et al. Principles for evidence-based drug formulary policy [J]. J Gen Intern Med, 2005, 20 (10): 964-968.
  • 2Bielory L. USP Model Guidelines Expert Committee. United States pharmacopeia development of the Medicare model formulary guidelines [J]. Am J Geriatr Cardiol, 2005, 14 (6): 301-307.
  • 3Lehunann D F, Guharoy, Page N, et al. Formulary rnanagement as a tool to improve medication use and gain physician support[J].AmJ Health Syst Pharm, 2007, 64 (5): 464-466.
  • 4Smetana G W, Davis R B, Phillips R S. Factors that influence patient response to requests to change to a unified restrictive formulary[J]. J Gen Intern Med, 2004, 19 (12): 1212-1219.
  • 5Olson B M. Approaches to pharmacy benefit management and the impact of consumer cost sharing [J] . Clin Ther, 2003, 25 (1): 250-272.
  • 6Schiff P L Jr, Srinivasan V S, Giancaspro G I, et al. The development of USP botanical dietary supplement monographs, 1995-2005 [J].J Nat Prod, 2006, 69 (3): 464-472.
  • 7Cantrill J A. Measuring the appropriateness of long-term prescribing in United Kingdom general practice-is the British National Formulary the "gold standard"? [J].J Clin Pharm Ther, 2000, 25 (5): 341-346.
  • 8Elias-Jones A, Rylance G. The launch of the British National Formulary for Children [J]. Arch Dis Child, 2005, 90 (10) : 997-998.
  • 9Goldsclunid A, Jacknowitz A I, Menczel E. The formulary of a large health maintenance organization in Israel [J] . Am J Health Syst Pharm, 2001, 58 (5): 420-421.
  • 10McCreadie S R, Stumpf J L, Benner T D. Building a better online formulary [J]. Am J Health Syst Pharm, 2002, 59 (19) : 1847-1852.

同被引文献62

  • 1敖翼,濮润,展勇,孙燕荣.我国新药创制的发展现状及问题浅析[J].中国新药杂志,2020,29(1):33-41. 被引量:19
  • 2黄哲,王文杰,刘玉颖,李慧.医疗机构药品选择模型的构建[J].沈阳药科大学学报,2020,37(3):275-281. 被引量:1
  • 3陆玲宝,许明哲.美国药典的历史沿革和现状[J].中国药事,2007,21(5):360-361. 被引量:10
  • 4贾晋生.我院处方集制定的原则与思路[J].中国规代药物应用,2008,2(20):125-126.
  • 5WHO. How to Develop a National Formulary Based on the WHO Model Formulary[EB/OL]. http..whqlibdoe.who.int/hq/2004/ WHO EDM PAR 2004.8.pdf.2004.2007-10-21.
  • 6Stolar MH. National survey of hospital pharmaceutical services-1985[J].{H}American Journal of Hospital Pharmacy,1985,(12):2667-2678.
  • 7Olson BM. Approaches to pharmacy benefit management and the impact of consumer cost sharing[J].{H}Clinical Therapeutice,2003,(01):250-272.
  • 8李雪墨.世卫组织发布首个《儿童标准处方集》同时支持各国制定自己的国家儿童处方集.
  • 9Summers KH,Szeinbach SL. Formularies:the role of pharmacy-and-therapeutics (P&T)committees[J].{H}Clinical Therapeutice,1993,(02):433-441.
  • 10Kendall M,Enright D. Provision of medicines information:the example of the British National Formulary[J].Br J Clin Pharma-col,2012,(06):934-938.

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部